LANTERN PHARMA INC (LTRN) Stock Ownership
NASDAQ:LTRN • US51654W1018
Current stock price
1.12 USD
-0.97 (-46.41%)
At close:
1.3 USD
+0.18 (+16.07%)
After Hours:
LTRN Ownership information
| Shares Outstanding | 11.18M |
| Float | 9.66M |
| Float Short Interest Percentage | 3.4% |
| Owners (insider) | 0.41% |
| Owners (institutional) | 19.96% |
| Owners (insider) change | 0% |
| Owners (institutional) change | -0.26% |
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Jun 13, 2025 | Kreis Leslie W. | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Cavu Management, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Cavu Advisors, LLC | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BP Directors, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Fletcher Aaron G.L. | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund I, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund I QP, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund II, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund II QP, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Fund II NT, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Bios Equity Partners, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | Bios Equity Partners II, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Capital Management, LP | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| Jun 13, 2025 | BIOS Advisors GP, LLC | Open Market Sale | 40000 | 3.09 | $ 123,600.00 |
| May 27, 2025 | Fletcher Aaron G.L. | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund I, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund I QP, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund II, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund II QP, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Fund II NT, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Bios Equity Partners, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Bios Equity Partners II, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Capital Management, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BIOS Advisors GP, LLC | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Kreis Leslie W. | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Cavu Management, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | Cavu Advisors, LLC | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |
| May 27, 2025 | BP Directors, LP | Open Market Sale | 56237 | 2.99 | $ 168,418.85 |